Oppenheimer & Co. Inc. Concludes Its Twenty-Seventh Healthcare Consumer Conference In New York City

NEW YORK, March 23, 2017 /PRNewswire/ -- Oppenheimer & Co. Inc. ("Oppenheimer") a unit of Oppenheimer Holdings (NYSE: OPY), recently hosted its 27^th Annual Healthcare Conference in New York City on March 21 and 22, 2017. The two-day conference brought together leading public and private companies across major sectors of the healthcare industry, including Cigna Corporation; Amgen, Inc.; Humana, Inc.; Teladoc, Inc.; and Centene Corp.

The event provided investors the opportunity to meet with more than 100 company management teams in one-on-one settings and small group meetings. Key panels included an interactive discussion on the issues with healthcare accessibility, cost and convenience; a discussion with noted biologists and biotech innovators on new areas of cancer science that could enter the market this year, and an interactive panel on genomics, gene regulation and gene editing.

The conference featured Oppenheimer's Senior Research Analysts who offered guidance on many aspects of the healthcare sector, including the following:

• Derek Archila, Executive Director and Senior Analyst covering Bio & Specialty Pharmaceuticals
• Leah Cann, Managing Director and Senior Analyst covering Biotechnology
• Steve Lichtman, Managing Director and Senior Analyst for Medical Devices
• Mohan Naidu, Managing Director and Senior Analyst covering the Healthcare Information Technology (HCIT) sector
• Jay Olson, Executive Director and Senior Analyst covering Biotechnology
• Hartaj Singh, Managing Director and Senior Analyst covering Biotechnology
• Mike Wiederhorn, Managing Director and Senior Analyst covering Healthcare Providers and Services

"This is a very dynamic time in the healthcare sector, from the current debate on the fate of the ACA and drug pricing to the exciting innovations being created in the laboratories. Our conference is especially timely and allows investors to delve into these issues and evaluate their outlook on the stocks for the foreseeable future," said Erica L. Moffett, Managing Director and Associate Director of Research at Oppenheimer.

Oppenheimer's next conference will be the 12th Annual Industrial Growth Conference, which will be held May 9-10, 2017 in New York City. The 2017 Emerging Growth Conference will also be held in New York City on May 16, 2017. Both meetings will provide opportunities for investors to meet a cross section of management teams across a number of different business models.

Oppenheimer & Co. Inc.
Oppenheimer & Co. Inc. (Oppenheimer), a principal subsidiary of Oppenheimer Holdings Inc. (OPY on the New York Stock Exchange), and its affiliates provide a full range of wealth management, securities brokerage and investment banking services to high-net-worth individuals, families, corporate executives, local governments, businesses and institutions.

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/oppenheimer--co-inc-concludes-its-twenty-seventh-healthcare-consumer-conference-in-new-york-city-300427019.html

SOURCE Oppenheimer & Co. Inc.